Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Case Reports in Oncology|December 12, 2019
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated MelanomaSara Bjursten, Christoffer Vannas, Stefan Filges, et al.Oncoimmunology|August 8, 2025
Immune-related hepatitis and hypophysitis are associated with superior survival in melanoma patients treated with combined ipilimumab and nivolumabHifaa Al Remawi, Maria Lindén, Zhiyuan Zhao, et al.Immunotherapy Advances|March 9, 2026
PD-1 inhibitor-induced rheumatic, endocrine, and sarcoidosis-like immune-related adverse events in metastatic melanoma are associated with improved survival and lower corticosteroid exposureMaria Lindén, Hifaa Al Remawi, Anna Fager, et al.Ebiomedicine|January 3, 2024
Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor-induced CNS inflammationSara Bjursten, Zhiyuan Zhao, Hifaa Al Remawi, et al.Journal for Immunotherapy of Cancer|July 3, 2021
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitisSara Bjursten, Ankur Pandita, Zhiyuan Zhao, et al.Frontiers in Immunology|February 22, 2024
Immune mapping of human tuberculosis and sarcoidosis lung granulomasBerit Carow, Victoria Muliadi, Kristina Skålén, et al.The American Journal of Pathology|August 17, 2021
Intussusceptive Angiogenesis in Human Metastatic Malignant MelanomaAnkur Pandita, Matias Ekstrand, Sara Bjursten, et al.Pageof 1